206 related articles for article (PubMed ID: 28258199)
1. Id2 Collaborates with Id3 To Suppress Invariant NKT and Innate-like Tumors.
Li J; Roy S; Kim YM; Li S; Zhang B; Love C; Reddy A; Rajagopalan D; Dave S; Diehl AM; Zhuang Y
J Immunol; 2017 Apr; 198(8):3136-3148. PubMed ID: 28258199
[TBL] [Abstract][Full Text] [Related]
2. Id3 and Id2 act as a dual safety mechanism in regulating the development and population size of innate-like γδ T cells.
Zhang B; Lin YY; Dai M; Zhuang Y
J Immunol; 2014 Feb; 192(3):1055-1063. PubMed ID: 24379125
[TBL] [Abstract][Full Text] [Related]
3. Combined deletion of Id2 and Id3 genes reveals multiple roles for E proteins in invariant NKT cell development and expansion.
Li J; Wu D; Jiang N; Zhuang Y
J Immunol; 2013 Nov; 191(10):5052-64. PubMed ID: 24123680
[TBL] [Abstract][Full Text] [Related]
4. E and Id proteins influence invariant NKT cell sublineage differentiation and proliferation.
D'Cruz LM; Stradner MH; Yang CY; Goldrath AW
J Immunol; 2014 Mar; 192(5):2227-36. PubMed ID: 24470501
[TBL] [Abstract][Full Text] [Related]
5. Id3 Restricts γδ NKT Cell Expansion by Controlling Egr2 and c-Myc Activity.
Zhang B; Jiao A; Dai M; Wiest DL; Zhuang Y
J Immunol; 2018 Sep; 201(5):1452-1459. PubMed ID: 30012846
[TBL] [Abstract][Full Text] [Related]
6. Essential functions for ID proteins at multiple checkpoints in invariant NKT cell development.
Verykokakis M; Krishnamoorthy V; Iavarone A; Lasorella A; Sigvardsson M; Kee BL
J Immunol; 2013 Dec; 191(12):5973-83. PubMed ID: 24244015
[TBL] [Abstract][Full Text] [Related]
7. ID2 and ID3 are indispensable for Th1 cell differentiation during influenza virus infection in mice.
Han X; Liu H; Huang H; Liu X; Jia B; Gao GF; Zhang F
Eur J Immunol; 2019 Mar; 49(3):476-489. PubMed ID: 30578645
[TBL] [Abstract][Full Text] [Related]
8. Transcription factor ID2 prevents E proteins from enforcing a naïve T lymphocyte gene program during NK cell development.
Zook EC; Li ZY; Xu Y; de Pooter RF; Verykokakis M; Beaulieu A; Lasorella A; Maienschein-Cline M; Sun JC; Sigvardsson M; Kee BL
Sci Immunol; 2018 Apr; 3(22):. PubMed ID: 29703840
[TBL] [Abstract][Full Text] [Related]
9. The E-Id protein axis modulates the activities of the PI3K-AKT-mTORC1-Hif1a and c-myc/p19Arf pathways to suppress innate variant TFH cell development, thymocyte expansion, and lymphomagenesis.
Miyazaki M; Miyazaki K; Chen S; Chandra V; Wagatsuma K; Agata Y; Rodewald HR; Saito R; Chang AN; Varki N; Kawamoto H; Murre C
Genes Dev; 2015 Feb; 29(4):409-25. PubMed ID: 25691468
[TBL] [Abstract][Full Text] [Related]
10. Id2 and Id3 maintain the regulatory T cell pool to suppress inflammatory disease.
Miyazaki M; Miyazaki K; Chen S; Itoi M; Miller M; Lu LF; Varki N; Chang AN; Broide DH; Murre C
Nat Immunol; 2014 Aug; 15(8):767-76. PubMed ID: 24973820
[TBL] [Abstract][Full Text] [Related]
11. Expression of Id2 and Id3 mRNA in human lymphocytes.
Ishiguro A; Spirin K; Shiohara M; Tobler A; Norton JD; Rigolet M; Shimbo T; Koeffler HP
Leuk Res; 1995 Dec; 19(12):989-96. PubMed ID: 8632670
[TBL] [Abstract][Full Text] [Related]
12. Transcriptional regulator Id2 controls survival of hepatic NKT cells.
Monticelli LA; Yang Y; Knell J; D'Cruz LM; Cannarile MA; Engel I; Kronenberg M; Goldrath AW
Proc Natl Acad Sci U S A; 2009 Nov; 106(46):19461-6. PubMed ID: 19884494
[TBL] [Abstract][Full Text] [Related]
13. The transcriptional regulators Id2 and Id3 control the formation of distinct memory CD8+ T cell subsets.
Yang CY; Best JA; Knell J; Yang E; Sheridan AD; Jesionek AK; Li HS; Rivera RR; Lind KC; D'Cruz LM; Watowich SS; Murre C; Goldrath AW
Nat Immunol; 2011 Nov; 12(12):1221-9. PubMed ID: 22057289
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of the HLH Id gene family in neural progenitors and glial cells of the rat spinal cord following contusion injury.
Tzeng SF; Bresnahan JC; Beattie MS; de Vellis J
J Neurosci Res; 2001 Dec; 66(6):1161-72. PubMed ID: 11746449
[TBL] [Abstract][Full Text] [Related]
15. Transcriptional regulator Id2 mediates CD8+ T cell immunity.
Cannarile MA; Lind NA; Rivera R; Sheridan AD; Camfield KA; Wu BB; Cheung KP; Ding Z; Goldrath AW
Nat Immunol; 2006 Dec; 7(12):1317-25. PubMed ID: 17086188
[TBL] [Abstract][Full Text] [Related]
16. ID helix-loop-helix proteins as determinants of cell survival in B-cell chronic lymphocytic leukemia cells in vitro.
Weiler S; Ademokun JA; Norton JD
Mol Cancer; 2015 Feb; 14(1):30. PubMed ID: 25644253
[TBL] [Abstract][Full Text] [Related]
17. Differential dependence on nuclear factor-κB-inducing kinase among natural killer T-cell subsets in their development.
Noma H; Eshima K; Satoh M; Iwabuchi K
Immunology; 2015 Sep; 146(1):89-99. PubMed ID: 25988531
[TBL] [Abstract][Full Text] [Related]
18. The helix-loop-helix protein Id2 is expressed differentially and induced by myc in T-cell lymphomas.
Cotta CV; Leventaki V; Atsaves V; Vidaki A; Schlette E; Jones D; Medeiros LJ; Rassidakis GZ
Cancer; 2008 Feb; 112(3):552-61. PubMed ID: 18085637
[TBL] [Abstract][Full Text] [Related]
19. Id2, Id3 and Id4 overcome a Smad7-mediated block in tumorigenesis, generating TGF-β-independent melanoma.
DiVito KA; Simbulan-Rosenthal CM; Chen YS; Trabosh VA; Rosenthal DS
Carcinogenesis; 2014 Apr; 35(4):951-8. PubMed ID: 24343358
[TBL] [Abstract][Full Text] [Related]
20. Functional antagonism between inhibitor of DNA binding (Id) and adipocyte determination and differentiation factor 1/sterol regulatory element-binding protein-1c (ADD1/SREBP-1c) trans-factors for the regulation of fatty acid synthase promoter in adipocytes.
Moldes M; Boizard M; Liepvre XL; Fève B; Dugail I; Pairault J
Biochem J; 1999 Dec; 344 Pt 3(Pt 3):873-80. PubMed ID: 10585876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]